Trellus Health (LSE:TRLS) Net Margin %: -1,017.97% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Trellus Health Net Margin %?

Trellus Health LSE:TRLS Net Margin % is -1,017.97% as of Jun. 2025. The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Trellus Health ranks worse than 98.05% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Trellus Health's Net Income for the six months ended in Jun. 2025 was £-2.21 Mil. Trellus Health's Revenue for the six months ended in Jun. 2025 was £0.22 Mil. Therefore, Trellus Health's net margin for the quarter that ended in Jun. 2025 was -1,017.97%.

The historical rank and industry rank for Trellus Health's Net Margin % or its related term are showing as below:

LSE:TRLS' s Net Margin % Range Over the Past 10 Years
Min: -48220   Med: -28372.28   Max: -1972.76
Current: -1972.76


LSE:TRLS's Net Margin % is ranked worse than
98.05% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 2.91 vs LSE:TRLS: -1972.76

Trellus Health  (LSE:TRLS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Trellus Health Net Margin % Related Terms


Trellus Health Net Margin % Historical Data

* Premium members only.

The historical data trend for Trellus Health's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trellus Health Net Margin % Chart

Trellus Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
0.00 -23,357.89 -48,220.00 -33,386.67 -6,840.00

Trellus Health Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -25,681.82 -54,750.00 -7,841.03 -6,035.29 -1,017.97

LSE:TRLS vs VEEV, BTSG, TEM: Net Margin % Comparison

For the Health Information Services subindustry, Trellus Health's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trellus Health Net Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's Net Margin % distribution charts can be found below:

* The bar in red indicates where Trellus Health's Net Margin % falls into.



Trellus Health Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Trellus Health's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-6.156/0.09
=-6,840.00 %

Trellus Health's Net Margin for the quarter that ended in Jun. 2025 is calculated as

Net Margin=Net Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-2.209/0.217
=-1,017.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1,017.97% mean?
Trellus Health (LSE:TRLS) has a Net Margin % of -1,017.97% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on Trellus Health and its competitors. According to the industry distribution chart, Trellus Health ranks #655 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 98.1%.
Is Trellus Health's Net Margin % too high?
Trellus Health's current Net Margin % is -1,017.97%. Based on the distribution chart, Trellus Health ranks #655 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Trellus Health's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #655 out of 668 companies for Net Margin %. This places Trellus Health in the lower half of its industry. The industry median Net Margin % is 2.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Trellus Health and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current Net Margin % is -1,017.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current Net Margin % of -1,017.97%. The current Net Margin % is -1,017.97%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current Net Margin % is -1,017.97% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trellus Health Business Description

Other Exchanges 85Q:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.